ARCHIVES

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 36 | October 2, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Clanton Resigns From NCI.

January 12, 2007

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

NLMs Grateful MED Aids Data Searches

March 21, 1986

Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me

December 13, 2013